Alithea Bio is a biotechnology company focused on developing innovative immunotherapies for cancer treatment. The company utilizes cutting-edge immunopeptidomics methods, highly sensitive mass spectrometry, and artificial intelligence to characterize HLA peptides. Its mission is to advance T-cell mediated immunotherapies and enhance therapeutic efficacy and safety through precise HLA peptide quantification.